The vaccine uses the same mRNA technology used to create Covid-19 jabs to tell the immune system to recognize a “foreign” protein on viruses and mount an attack, in this case targeting three major strains of norovirus. Results so far have shown it creates a “strong immune response”.
UK could be first country to offer norovirus jab against ‘winter vomiting bug’
New vaccine could stop people developing the highly infectious illness after early trial results found it creates a ‘strong immune response’
23 October 2024 6:32am BST
23 October 2024 6:32am BST
Britain could become the first country to offer norovirus jab after early trial results found it creates a “strong immune response”.
Wes Streeting, the Health Secretary, said achieving the world-first could reduce the “huge strain” the NHS faces every winter and save taxpayers millions.
Scientists hope the new vaccine from Moderna could stop people developing the vomiting and diarrhoea bug, which often spreads in care homes and is linked to around 12,000 hospital admissions in Britain every year.
The jab will enter final stages of testing within the next two weeks.
The jab uses mRNA technology to tell the immune system to recognise a “foreign” protein on viruses and mount an attack, in this case targeting three major strains of norovirus.
Mr Streeting said: “Norovirus is highly infectious and puts the NHS under huge strain every winter, costing taxpayers around £100 million a year.
“The UK is leading the way to develop a world-first vaccine for this vomiting bug, starting with this innovative vaccine trial delivered through the Government-funded National Institute for Health and Care Research.
“Not only is this a huge vote of confidence in the UK’s life sciences sector, but a successful vaccine will help shift our health system away from sickness and towards prevention – reducing pressure on the NHS and keeping people well during the colder months.”
Wes Streeting, the Health Secretary, said achieving the world-first could reduce the “huge strain” the NHS faces every winter and save taxpayers millions.
Scientists hope the new vaccine from Moderna could stop people developing the vomiting and diarrhoea bug, which often spreads in care homes and is linked to around 12,000 hospital admissions in Britain every year.
The jab will enter final stages of testing within the next two weeks.
The jab uses mRNA technology to tell the immune system to recognise a “foreign” protein on viruses and mount an attack, in this case targeting three major strains of norovirus.
Mr Streeting said: “Norovirus is highly infectious and puts the NHS under huge strain every winter, costing taxpayers around £100 million a year.
“The UK is leading the way to develop a world-first vaccine for this vomiting bug, starting with this innovative vaccine trial delivered through the Government-funded National Institute for Health and Care Research.
“Not only is this a huge vote of confidence in the UK’s life sciences sector, but a successful vaccine will help shift our health system away from sickness and towards prevention – reducing pressure on the NHS and keeping people well during the colder months.”
.png)
No comments:
Post a Comment